Figure 2.
Changes in central retinal thickness (CRT) for tAMD and PCV patients after intravitreal ranibizumab. Diamonds with dashed lines: tAMD; squares with solid lines: PCV. Values represent means ± SEM.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.